Search research articles
Contact Us
Filters
Showing results (31-40 of 71) with videos related to
Page
of 8
Sort By:
Cells
|
October 27, 2022
High-Dimensional Cytometry Dissects Immunological Fingerprints of Idiopathic Inflammatory Myopathies
Christopher Nelke, Marc Pawlitzki, Christina B Schroeter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
October 20, 2021
Evaluation of Age-Dependent Immune Signatures in Patients With Multiple Sclerosis
Melanie Eschborn, Marc Pawlitzki, Timo Wirth, et al.
International Journal of Molecular Sciences
|
November 2, 2016
Tocotrienol Affects Oxidative Stress, Cholesterol Homeostasis and the Amyloidogenic Pathway in Neuroblastoma Cells: Consequences for Alzheimer's Disease
Marcus O W Grimm, Liesa Regner, Janine Mett, et al.
Acta Neuropathologica
|
September 29, 2023
Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis
Christopher Nelke, Christina B Schroeter, Lukas Theissen, et al.
Cells
|
March 27, 2024
Recombinant Acetylcholine Receptor Immunization Induces a Robust Model of Experimental Autoimmune Myasthenia Gravis in Mice
Lukas Theissen, Christina B Schroeter, Niklas Huntemann, et al.
Scientific Reports
|
October 3, 2024
Molecular composition of skeletal muscle in infants and adults: a comparative proteomic and transcriptomic study
Alexander Schaiter, Andreas Hentschel, Felix Kleefeld, et al.
International Journal of Molecular Sciences
|
December 20, 2017
Vitamin D and Its Analogues Decrease Amyloid-β (Aβ) Formation and Increase Aβ-Degradation
Marcus O W Grimm, Andrea Thiel, Anna A Lauer, et al.
Frontiers in Immunology
|
August 21, 2023
Classifying flow cytometry data using Bayesian analysis helps to distinguish ALS patients from healthy controls
Saskia Räuber, Christopher Nelke, Christina B Schroeter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
July 15, 2021
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19
Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, et al.
Journal of Neurology
|
April 18, 2025
Risk factors and clinical significance of neurodegenerative co-pathologies in symptomatic cerebral small vessel disease
Philipp Arndt, Malte Pfister, Valentina Perosa, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 71) with videos related to
Sort By:
Page
of 8
Cells
|
October 27, 2022
High-Dimensional Cytometry Dissects Immunological Fingerprints of Idiopathic Inflammatory Myopathies
Christopher Nelke, Marc Pawlitzki, Christina B Schroeter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
October 20, 2021
Evaluation of Age-Dependent Immune Signatures in Patients With Multiple Sclerosis
Melanie Eschborn, Marc Pawlitzki, Timo Wirth, et al.
International Journal of Molecular Sciences
|
November 2, 2016
Tocotrienol Affects Oxidative Stress, Cholesterol Homeostasis and the Amyloidogenic Pathway in Neuroblastoma Cells: Consequences for Alzheimer's Disease
Marcus O W Grimm, Liesa Regner, Janine Mett, et al.
Acta Neuropathologica
|
September 29, 2023
Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis
Christopher Nelke, Christina B Schroeter, Lukas Theissen, et al.
Cells
|
March 27, 2024
Recombinant Acetylcholine Receptor Immunization Induces a Robust Model of Experimental Autoimmune Myasthenia Gravis in Mice
Lukas Theissen, Christina B Schroeter, Niklas Huntemann, et al.
Scientific Reports
|
October 3, 2024
Molecular composition of skeletal muscle in infants and adults: a comparative proteomic and transcriptomic study
Alexander Schaiter, Andreas Hentschel, Felix Kleefeld, et al.
International Journal of Molecular Sciences
|
December 20, 2017
Vitamin D and Its Analogues Decrease Amyloid-β (Aβ) Formation and Increase Aβ-Degradation
Marcus O W Grimm, Andrea Thiel, Anna A Lauer, et al.
Frontiers in Immunology
|
August 21, 2023
Classifying flow cytometry data using Bayesian analysis helps to distinguish ALS patients from healthy controls
Saskia Räuber, Christopher Nelke, Christina B Schroeter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
July 15, 2021
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19
Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, et al.
Journal of Neurology
|
April 18, 2025
Risk factors and clinical significance of neurodegenerative co-pathologies in symptomatic cerebral small vessel disease
Philipp Arndt, Malte Pfister, Valentina Perosa, et al.
Page
of 8